E-cadherin: a marker for differentiation and invasiveness in prostatic carcinoma
- PMID: 7506464
- DOI: 10.1007/BF00296837
E-cadherin: a marker for differentiation and invasiveness in prostatic carcinoma
Abstract
Considerable controversy exists concerning the value of histomorphological data in the assessment of the malignant potential of prostatic carcinomas. We investigated the expression pattern of E-cadherin in human prostate at the translational level. E-cadherin is a specific epithelial cell-cell adhesion molecule which has previously been found to be expressed in well-differentiated non-invasive carcinoma cell lines but is lost in many poorly differentiated invasive cell lines. The E-cadherin expression pattern in the prostate samples was correlated with histopathological findings in the same specimens. We found strong E-cadherin expression in normal prostate and benign prostatic hyperplasia. A decrease in or loss of E-cadherin was seen in 13 of 14 locally advanced and in 8 of 9 poorly differentiated prostatic carcinomas. We conclude that downregulation of E-cadherin expression plays a role in prostate carcinogenesis and invasiveness.
Similar articles
-
Co-ordinated changes in expression of cell adhesion molecules in prostate cancer.Eur J Cancer. 1997 Feb;33(2):263-71. doi: 10.1016/s0959-8049(96)00418-2. Eur J Cancer. 1997. PMID: 9135498
-
The intercellular adhesion molecule, cadherin-10, is a marker for human prostate luminal epithelial cells that is not expressed in prostate cancer.Mod Pathol. 2008 Feb;21(2):85-95. doi: 10.1038/modpathol.3800988. Epub 2007 Dec 14. Mod Pathol. 2008. PMID: 18084254
-
Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer.Histopathology. 2007 Apr;50(5):648-58. doi: 10.1111/j.1365-2559.2007.02665.x. Histopathology. 2007. PMID: 17394502
-
The cadherin cell-cell adhesion pathway in prostate cancer progression.Br J Urol. 1997 Mar;79 Suppl 1:37-43. doi: 10.1111/j.1464-410x.1997.tb00799.x. Br J Urol. 1997. PMID: 9088271 Review.
-
Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: biological significance and clinical implications.Cancer Metastasis Rev. 1993 Mar;12(1):29-37. doi: 10.1007/BF00689788. Cancer Metastasis Rev. 1993. PMID: 8448824 Review. No abstract available.
Cited by
-
Progressive epithelial to mesenchymal transitions in ARCaP E prostate cancer cells during xenograft tumor formation and metastasis.Prostate. 2010 Apr 1;70(5):518-28. doi: 10.1002/pros.21086. Prostate. 2010. PMID: 19918799 Free PMC article.
-
Prognostic factors for bladder cancer.Urol Res. 1995;23(3):137-41. doi: 10.1007/BF00389564. Urol Res. 1995. PMID: 7483138 Review.
-
Inverse correlation between mRNA expression of plasminogen activator inhibitor-2 and lymph node metastasis in human breast cancer.Jpn J Cancer Res. 1996 May;87(5):480-7. doi: 10.1111/j.1349-7006.1996.tb00249.x. Jpn J Cancer Res. 1996. PMID: 8641985 Free PMC article.
-
E-, N- and P-cadherin, and alpha-, beta- and gamma-catenin protein expression in normal, hyperplastic and carcinomatous human prostate.Histochem J. 2000 Nov;32(11):659-67. doi: 10.1023/a:1004111331752. Histochem J. 2000. PMID: 11272805
-
Methyl Donors Reduce Cell Proliferation by Diminishing Erk-Signaling and NFkB Levels, While Increasing E-Cadherin Expression in Panc-1 Cell Line.Int J Mol Sci. 2022 Feb 25;23(5):2546. doi: 10.3390/ijms23052546. Int J Mol Sci. 2022. PMID: 35269689 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical